Two articles in the June issue of The Journal of Nuclear Medicine make a case for maintaining current U.S. Nuclear Regulatory Commission (NRC) regulations on the release of patients who undergo radioactive iodine treatments for thyroid cancer. Currently, the NRC recommends outpatient treatment...